Every week, millions of Americans fill prescriptions for GLP-1 receptor agonists, drugs like Ozempic and Wegovy
These bioactive peptides support collagen synthesis, reinforce the skins barrier, and help reduce early signs of dullness and fatigue
However, distinguishing kidney stone symptoms from the common gastrointestinal side effects of GLP-1 receptor agonists can be challenging
Understanding the difference between medications like Mounjaro vs Zepbound can also clarify your treatment path
"By reducing barriers like travel or scheduling, it makes frequent patient check-ins much easier
What clinical trials show Large-scale clinical trials have measured average weight loss across thousands of participants: Wegovy (semaglutide 2.4 mg) : Participants in the STEP 1 trial lost an average of 14.9% of their body weight over 68 weeks